Combination and tricombination therapy to destabilize the structural integrity of COVID-19 by some bioactive compounds with antiviral drugs: insights from molecular docking study

Recently, the SARS-CoV-2 (COVID-19) pandemic virus has been spreading throughout the world. Until now, no certified drugs have been discovered to efficiently inhibit the virus. The scientists are struggling to find new safe bioactive inhibitors of this deadly virus. In this study, we aim to find ant...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Mageed, H. R. Abd, Abdelrheem, Doaa A., Ahmed, Shimaa A., Rahman, Aziz A., Elsayed, Khaled N. M., Ahmed, Sayed A., EL-Bassuony, Ashraf A., Mohamed, Hussein S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791912/
https://www.ncbi.nlm.nih.gov/pubmed/33437137
http://dx.doi.org/10.1007/s11224-020-01723-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791912/
https://www.ncbi.nlm.nih.gov/pubmed/33437137
http://dx.doi.org/10.1007/s11224-020-01723-5

Ejemplares similares